Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
Chemical Biology & Drug Design|November 1, 2015
Sirtuins are Unaffected by PARP Inhibitors Containing Planar Nicotinamide BioisosteresTorun Ekblad, Herwig SchülerThe FEBS Journal|April 23, 2013
PARP inhibitors: polypharmacology versus selective inhibitionTorun Ekblad, Emidio Camaioni, Herwig Schüler, et al.European Journal of Nuclear Medicine and Molecular Imaging|September 23, 2009
(186)Re-maSGS-Z (HER2:342), a potential Affibody conjugate for systemic therapy of HER2-expressing tumoursAnna Orlova, Thuy A Tran, Torun Ekblad, et al.Bioorganic & Medicinal Chemistry Letters|April 15, 2009
Positioning of 99mTc-chelators influences radiolabeling, stability and biodistribution of Affibody moleculesTorun Ekblad, Anna Orlova, Joachim Feldwisch, et al.Biopolymers|January 14, 2009
Synthesis and chemoselective intramolecular crosslinking of a HER2-binding affibodyTorun Ekblad, Vladimir Tolmachev, Anna Orlova, et al.SLAS Discovery : Advancing Life Sciences R & D|January 11, 2018
Identification of Poly(ADP-Ribose) Polymerase Macrodomain Inhibitors Using an AlphaScreen ProtocolTorun Ekblad, Patricia Verheugd, Anders E Lindgren, et al.European Journal of Nuclear Medicine and Molecular Imaging|July 3, 2008
Development and preclinical characterisation of 99mTc-labelled Affibody molecules with reduced renal uptakeTorun Ekblad, Thuy Tran, Anna Orlova, et al.Bioconjugate Chemistry|November 28, 2008
Effects of lysine-containing mercaptoacetyl-based chelators on the biodistribution of 99mTc-labeled anti-HER2 Affibody moleculesThuy A Tran, Torun Ekblad, Anna Orlova, et al.Journal of Medicinal Chemistry|December 22, 2016
Structural Basis for Potency and Promiscuity in Poly(ADP-ribose) Polymerase (PARP) and Tankyrase InhibitorsAnn-Gerd Thorsell, Torun Ekblad, Tobias Karlberg, et al.European Journal of Medicinal Chemistry|April 8, 2015
Towards small molecule inhibitors of mono-ADP-ribosyltransferasesTorun Ekblad, Anders E G Lindgren, C David Andersson, et al.Pageof 2